| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$9 |
Update on Qcide Production
|
10 Mar 2026 9:28AM |
$0.035 |
$0.029 |
fallen by
17.14%
|
|
| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$31 |
Update - Notification of buy-back - KME
|
10 Mar 2026 9:28AM |
$0.570 |
$0.570 |
fallen by
0%
|
|
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$4 |
OSX and NUH to co-develop surgical guide in neurosurgery
|
10 Mar 2026 9:27AM |
$0.008 |
$0.007 |
fallen by
18.75%
|
|
| Western Gold Resources Limited (WGR) ORDINARY FULLY PAID |
Materials |
$41 |
121 Mining Investment Conference Presentation - Gold Duke
|
10 Mar 2026 9:27AM |
$0.190 |
$0.140 |
fallen by
26.32%
|
|
WGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Gold Duke Project Stage 1 fully approved.
- Production target of 686kt @ 2.1g/t Au for 42,800 ounces.
- Projected cash surplus of $56.1M at A$4,500/oz.
- 3-month payback period and 14-month total mine plan.
- Binding Toll Milling Agreement with Wiluna Mining Corporation.
- SSH Mining Australia to provide mining services with deferred payment facility.
- Exploration and resource extensions planned for project growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nex Metals Exploration Limited (NME) ORDINARY FULLY PAID |
Materials |
$6 |
Gold Projects and Exploration Update
|
10 Mar 2026 9:26AM |
$0.014 |
$0.019 |
risen by
35.71%
|
|
NME - Price-sensitive ASX Announcement
Full Release
Key Points
- Commencement of metallurgical testing at Kookynie Tailings Project.
- Partnership with WTAC for Western Australian projects under profit-sharing arrangements.
- Strategic entry into Egypt's Eastern Desert delayed by geopolitical conditions.
- Proposed divestment of Arika Joint Venture for cash and shares.
- Focus on establishing independent processing capabilities to reduce reliance on toll processors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$23,042 |
Notification of cessation of securities - BXB
|
10 Mar 2026 9:26AM |
$23.230 |
$17.110 |
fallen by
26.35%
|
|
| L1 Group Limited (L1G) ORDINARY FULLY PAID |
Financials |
$2,798 |
Notification regarding unquoted securities - L1G
|
10 Mar 2026 9:24AM |
$1.200 |
$1.090 |
fallen by
9.17%
|
|
| Clime Investment Management Ltd (CIW) ORDINARY FULLY PAID |
Financials |
$26 |
Update - Notification of buy-back - CIW
|
10 Mar 2026 9:24AM |
$0.330 |
$0.315 |
fallen by
4.55%
|
|
| Vulcan Steel Limited (VSL) ORDINARY FULLY PAID |
Materials |
$794 |
Update - Dividend/Distribution - VSL
|
10 Mar 2026 9:24AM |
$6.450 |
$5.420 |
fallen by
15.97%
|
|
| Polymetals Resources Ltd (POL) ORDINARY FULLY PAID |
Materials |
$264 |
Appendix 3Y-Sproule
|
10 Mar 2026 9:22AM |
$0.900 |
$0.860 |
fallen by
4.44%
|
|
| EQT Holdings Limited (EQT) ORDINARY FULLY PAID |
Financials |
$435 |
Notification regarding unquoted securities - EQT
|
10 Mar 2026 9:22AM |
$20.080 |
$16.230 |
fallen by
19.17%
|
|
| Kingsland Minerals Ltd (KNG) ORDINARY FULLY PAID |
Materials |
$6 |
Outstanding assays from surface from Leliyn Graphite Project
|
10 Mar 2026 9:22AM |
$0.082 |
$0.071 |
fallen by
13.41%
|
|
KNG - Price-sensitive ASX Announcement
Full Release
Key Points
- Outstanding assay results from Leliyn Graphite Project.
- High total graphitic carbon percentages in drill results.
- Metallurgical tests to determine graphite suitability for battery anodes.
- Binding offtake agreement with Quinbrook.
- Approval for extensive infill drilling program.
- Leliyn is a significant graphite deposit with development potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nanosonics Limited (NAN) ORDINARY FULLY PAID |
Health Care |
$983 |
Update - Notification of buy-back - NAN
|
10 Mar 2026 9:22AM |
$3.570 |
$3.290 |
fallen by
7.84%
|
|
| Dexus (DXS) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$6,521 |
Update - Notification of buy-back - DXS
|
10 Mar 2026 9:21AM |
$6.220 |
$6.080 |
fallen by
2.25%
|
|
| Ion Video Ltd (IOV) ORDINARY FULLY PAID |
Information Technology |
$39 |
Independent Validation of New Patent Filing
|
10 Mar 2026 9:21AM |
$0.210 |
$0.390 |
risen by
85.71%
|
|
| Laramide Resources Ltd (LAM) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$204 |
Notification regarding unquoted securities - LAM
|
10 Mar 2026 9:21AM |
$0.830 |
$0.720 |
fallen by
13.25%
|
|
| Terra Critical Minerals Limited (T92) ORDINARY FULLY PAID |
Energy |
$10 |
Change in substantial holding
|
10 Mar 2026 9:21AM |
$0.140 |
$0.065 |
fallen by
53.57%
|
|
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$123 |
Dimerix Phase 3 Trial Last Patient Receives First Dose
|
10 Mar 2026 9:21AM |
$0.375 |
$0.205 |
fallen by
45.33%
|
|
DXB - Price-sensitive ASX Announcement
Full Release
Key Points
- 333 patients have been randomised and dosed in the ACTION3 Phase 3 clinical study.
- The final enrolment reached 333 adult patients in the ACTION3 Phase 3 trial.
- Paediatric patient recruitment remains ongoing as an independent cohort.
- The full 2-year study is expected to complete in March 2028.
- The trial has successfully passed seven scheduled Independent Data Monitoring Committee reviews.
- The ACTION3 Phase 3 study is a pivotal multi-centre, randomised, double-blind, placebo-controlled study.
- The study is aimed at generating evidence of proteinuria reduction and kidney function (eGFR slope).
- Dimerix plans further steps including a statistical analysis of the ACTION3 study in line with FDA guidance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tetratherix Limited (TTX) ORDINARY FULLY PAID |
Health Care |
$189 |
Tutelix Update
|
10 Mar 2026 9:21AM |
$3.810 |
$6.940 |
risen by
82.15%
|
|
TTX - Price-sensitive ASX Announcement
Full Release
Key Points
- Tutelix is a clinician-friendly spacer for prostate cancer radiation therapy.
- Enables higher radiation doses in shorter timeframes.
- Series A funding round completed, raising approximately $5 million.
- Clinical trials progressing in Australia and the US.
- US-FDA 510(k) clearance expected by 2028.
- No adverse events reported in trials, demonstrating safety and efficacy.
- Product offers commercial potential with superior performance and cost benefits.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metal Bank Limited (MBK) ORDINARY FULLY PAID |
Materials |
$12 |
Outstanding Gold Recovery Results for Seven Leaders
|
10 Mar 2026 9:19AM |
$0.023 |
$0.014 |
fallen by
39.13%
|
|
MBK - Price-sensitive ASX Announcement
Full Release
Key Points
- Single pass Falcon gravity gold recovery of 72.5%
- Intensive leaching recovered >99% of gold
- Bottle roll leaching recovered 92.6% from Falcon tails
- High nugget effect indicating potential grade upside
- JORC 2012 Mineral Resource Estimate: 138,000t @ 1.4g/t Au
- Whiteheads Gold Project covers ~380km², 80km NE of Kalgoorlie
- MBK committed to expediting WA gold production strategy
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| COSOL Limited (COS) ORDINARY FULLY PAID |
Information Technology |
$36 |
Notification of cessation of securities - COS
|
10 Mar 2026 9:17AM |
$0.230 |
$0.200 |
fallen by
13.04%
|
|
| Polymetals Resources Ltd (POL) ORDINARY FULLY PAID |
Materials |
$264 |
Notification of cessation of securities - POL
|
10 Mar 2026 9:17AM |
$0.900 |
$0.860 |
fallen by
4.44%
|
|
| North Stawell Minerals Ltd (NSM) ORDINARY FULLY PAID |
Materials |
$10 |
Air Core Commences at Caledonia and Darlington Projects
|
10 Mar 2026 9:14AM |
$0.030 |
$0.027 |
fallen by
11.67%
|
|
NSM - Price-sensitive ASX Announcement
Full Release
Key Points
- Air core drilling program of 2,000-2,500 meters commenced.
- Projects located at Caledonia and Darlington, Victoria.
- NSD057 drill hole at Darlington revealed 2.3m at 29.3 g/t Au.
- Darlington mineralisation parallels historic trends, open in all directions.
- Caledonia and Darlington are priority targets along a 3.6 km trend.
- Victorian-based AMWD conducting the drilling.
- Results anticipated by early to mid-April 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DPM Metals Inc. (DPM) CDI 1:1 FOREIGN EXEMPT TSX |
Materials |
$10,903 |
DPM Announces Filing of Technical Report for Chelopech Mine
|
10 Mar 2026 9:14AM |
$54.970 |
$45.870 |
fallen by
16.55%
|
|
DPM - Price-sensitive ASX Announcement
Full Release
Key Points
- DPM Metals Inc. announced the filing of a technical report for the Chelopech mine.
- The report aligns with NI 43-101 standards for mineral projects.
- It supports updates to the Mineral Resource and Reserve estimates and life of mine plan.
- DPM aims to become a mid-tier precious metals company.
- The report and related news releases are available on SEDAR+ and the company's website.
- The company operates in Bulgaria, Bosnia and Herzegovina, Serbia, and Ecuador.
- DPM trades on the Toronto and Australian Stock Exchanges.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Black Rock Mining Limited (BKT) ORDINARY FULLY PAID |
Materials |
$30 |
Half Year Report and Accounts
|
10 Mar 2026 9:13AM |
$0.017 |
$0.014 |
fallen by
17.65%
|
|
Call 1300 880 160
Start a chat
Schedule a call
